Normalisation of immune cell imbalance after pharmacological treatments of patients suffering from obsessive-compulsive disorder

Journal of Psychopharmacology

Volumn 23, Issue 5, 2009, Pages 567-573

  Marazziti, D ^a   Mungai, F ^a   Masala, I ^a   Baroni, S ^a   Vivarelli, L ^a   Ambrogi, F ^a   Catena Dellosso, M ^a   Consoli, G ^a   Massimetti, G ^a   Dellosso, L ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Adulthood; Immunological cells; Obsessive compulsive disorder; Pharmacological treatments; T helper cells; T lymphocyte subsets; T suppressor cells

Indexed keywords

CD16 ANTIGEN; CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; CITALOPRAM; CLOMIPRAMINE; FLUVOXAMINE; SERTRALINE;

ADOLESCENT; ADULT; ARTICLE; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; LYMPHOCYTE COUNT; MALE; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIGENS, CD; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CLOMIPRAMINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS; YOUNG ADULT;

EID: 67449147405     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881108089605     Document Type: Article

References (86)

1. Afoke AO., Eeg-Olofsson O., Hed J., Kjellman NI., Lindblom B., Ludvigsson J., (1993) Seasonal variation and sex differences of circulating macrophages, immunoglobulins and lymphocytes in healthy school children. Scand J Immunol 37: 209-215. (Pubitemid 23063664)
2. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, fourth ed. Washington, DC: American Psychiatric Press.
3. Sberg M., Thoren P., Bertilsson L., (1981) Clomipramine treatment of obsessive disorder: biochemical and clinical aspects. Psychopharmacol Bull 18: 13-21.
4. Barber Y., Toren P., Achiron A., Noy S., Wolmer L., Weizman R., (1996) T cell subsets in obsessive-compulsive disorder. Neuropsychobiology 34: 63-66. (Pubitemid 26329100)
5. Bastani B., Arora RC., Meltzer HY., (1991) Serotonin uptake and imipramine binding in the blood platelets of obsessive-compulsive disorder patients. Biol Psychiatry 30: 131-139.
6. Bauer ME., Gauer GJ., Luz C., Silveira RO., Nardi NB., Von Muhlen CA., (1995) Evaluation of immune parameters in depressed patients. Life Sci 57: 665-674.
7. Bennett HT., Cohen S., (1993) Depression and immunity: a meta-analytic review. Psychol Bull 113: 472-483.
8. Brambilla F., Perna G., Bellodi L., Arancio C., Bertani A., Perini G., (1997) Plasma interleukin-1 beta and tumor necrosis factor concentrations in obsessive-compulsive disorders. Biol Psychiatry 42: 976-981. (Pubitemid 27496427)
9. Bronze MS., Dale JB., (1993) Epitopes of streptococcal M proteins that evoke antibodies that cross-react with human brain. J Immunol 151: 2820-2828. (Pubitemid 23264534)
10. Carpenter LL., Heninger GR., McDougle CJ., Tyrka AR., Epperson CN., Price LH., (2002) Cerebrospinal fluid interleukin-6 in obsessive-compulsive disorder and trichotillomania. Psychiatry Res 112: 257-262. (Pubitemid 35351727)
11. Chu L., Tian S., Chen H., Zhou Z., (2002) Study on natural killer cell subset and activity in patients with depression. Zhonghua Yi Xue Za Zhi 82: 830-831.
12. Creti R., Cardona F., Pataracchia M., Hunolstein CV., Cundari G., Romano A., (2004) Characterisation of group a streptococcal (GAS) isolates from children with tic disorders. Indian J Med Res 119: 174-178. (Pubitemid 39004473)
13. Denckla MB., Rapoport JL., (1989) Neurological examination. In: MB Denckla., JL Rapoport., (eds). Obsessive-Compulsive Disorder in Children and Adolescents. Washington, DC: American Psychiatric Press, pp. 107-118.
14. Denys D., Fluitman S., Kavelaars A., Heijnen C., Westenberg H., (2004) Decreased TNF-alpha and NK activity in obsessive-compulsive disorder. Psychoneuroendocrinology 29: 945-952. (Pubitemid 38716121)
15. Denys D., Fluitman S., Kavelaars A., Heijnen C., Westenberg HG., (2006) Effects of paroxetine and venlafaxine on immune parameters in patients with obsessive-compulsive disorder. Psychoneuroendocrinology 31: 355-360. (Pubitemid 43261655)
16. Dinn WM., Harris CL., McGonigal KM., Raynard RC., (2001) Obsessive-compulsive disorder and immunocompetence. Int J Psychiatry Med 31: 311-320. (Pubitemid 34112932)
17. Dorian B., Garfinkel PE., (1987) Stress, immunity and illness-a review. Psychol Med 17: 393-407.
18. Eisen JL., Leonard HL., Swedo SE., Price LH., Zabriskie JB., Chiang SY., (2001) The use of antibody D8/17 to identify B cells in adults with obsessive-compulsive disorder. Psychiatry Res 104: 221-225. (Pubitemid 33135503)
19. Fineberg N., (1996) Refining treatment approaches in obsessive-compulsive disorder. J Clin Psychopharmacol 11: 13-22. (Pubitemid 27049278)
20. First MB; .,Spitzer RL; .,Gibbon M; .,Williams JBW; ., (1997) Structured Clinical Interview for DSM-IV Axis I Disorders - Patient Edition (SCID-I/P, Version 2.0, 4/97 revision). Biometrics Research Department, New York State Psychiatric Institute.
21. Garvey MA., Perlmutter SJ., Allen AJ., Hamburger S., Lougee L., Leonard HL., (1999) A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections. Biol Psychiatry 45: 1564-1571. (Pubitemid 29292832)
22. Gibofsky A., Khanna A., Suh E., Zabriskie JB., (1991) The genetics of rheumatic fever: relationship to streptococcal infection and autoimmune disease. J Rheumatol 30: 1-5.
23. Goodman WK., Price LH., Rasmussen SA., (1986) The Yale Brown obsessive-compulsive scale I: development, use and reliability. Arch Gen Psychiatry 46: 1006-1011.
24. Greist JH., Bandelow B., Hollander E., Marazziti D., Montgomery SA., Nutt DJ., (2003) WCA recommendations for the long-term treatment of obsessive-compulsive disorder in adults. CNS Spectr 8: 7-16. (Pubitemid 38419777)
25. Hollander E., Cartwright C., Wong CM., De Caria CM., Del Giudice-Asch G., Buchsbaum MS., (1998) A dimensional approach to the autism spectrum. CNS Spectr 3: 22-99.
26. Hollander E., Fay M., Cohen B., Campeas R., Gorman JM., Liebowitz MR., (1988) Serotonergic and noradrenergic sensitivity in obsessive-compulsive disorder: behavioral findings. Arch Gen Psychiatry 145: 1015-1023.
27. Hollander E., Kaplan A., Allen A., Cartwright C., (2000) Pharmacotherapy for obsessive-compulsive disorder. Psychiatr Clin North Am 23: 643-656. (Pubitemid 30666512)
28. Hounie AG., Pauls DL., do Rosario-Campos MC., Mercadante MT., Diniz JB., De Mathis MA., (2007) Obsessive-compulsive spectrum disorders and rheumatic fever: a family study. Biol Psychiatry 61: 266-272. (Pubitemid 46108680)
29. Inoff-Germain G., Rodriguez RS., Torres-Alcantara S., Diaz-Jimenez MJ., Swedo SE., Rapoport JL., (2003) An immunological marker (D8/17) associated with rheumatic fever as a predictor of childhood psychiatric disorders in a community sample. J Child Psychol Psychiatry 44: 782-790. (Pubitemid 36944004)
30. Insel TR., Mueller EA., Alterman L., Linnoila M., Murphy DL., (1985) Obsessive-compulsive disorder and serotonin: is there a connection? Biol Psychiatry 20: 1174-1188. (Pubitemid 16053592)
31. Irwin M., (1999) Immune correlates of depression. Adv Exp Med Biol 461: 1-24.
32. Kawikova I., Leckman JF., Kronig H., Katsovich L., Bessen DE., Ghebremichael M., (2007) Decreased numbers of regulatory T cells suggest impaired immune tolerance in children with Tourette syndrome: a preliminary study. Biol Psychiatry 61: 273-278. (Pubitemid 46108689)
33. Khanna S., Ravi V., Shenoy PK., Chandramuki A., Channabasavanna SM., (1997) Cerebrospinal fluid viral antibodies in obsessive-compulsive disorder in an Indian population. Biol Psychiatry 41: 883-890. (Pubitemid 27158386)
34. Kiecolt-Glaser JK., Fisher LD., Ogrocki P., Stout JC., Speicher CE., Glaser R., (1987) Marital quality, marital disruption, and immune function. Psychosom Med 49: 13-34. (Pubitemid 17029330)
35. Kim YR., Park Q., Yu BH., (2004) Changes in lymphocyte subsets after short-term pharmacotherapy in patients with panic disorder. Psychiatry Res 128: 183-190. (Pubitemid 39369870)
36. Leckman JF., Katsovich L., Kawikova I., Lin H., Zhang H., Kronig H., (2005) Increased serum levels of interleukin-12 and tumor necrosis factor-alpha in Tourette™s syndrome. Biol Psychiatry 57: 667-673. (Pubitemid 40409706)
37. Lee BW., Yap HK., Chew FT., Quah TC., Prabhakaran K., Chan GS., (1996) Age- and sex-related changes in lymphocyte subpopulations of healthy Asian subjects: from birth to adulthood. Cytometry 26: 8-15.
38. Maes M., Meltzer HY., Bosmans E., (1994) Psychoimmune investigation in obsessive-compulsive disorder: assays of plasma transferrin, IL-2 and IL-6 receptor, and IL-1 beta and IL-6 concentrations. Neuropsychobiology 30: 57-60. (Pubitemid 24284802)
39. Marazziti D., Ambrogi F., Vanacore R., Magnani V., Savino M., Palego L., (1992a) Immune cell imbalance in major depressive and panic disorder. Neuropsychobiology 26: 23-26.
40. Marazziti D., Catena M., Pallanti S., (2006) Pharmacological treatment of obsessive-compulsive disorder. Psychiatr Ann 36: 454-462.
41. Marazziti D., Hollander E., Lensi P., Ravagli S., Cassano GB., (1992b) Peripheral markers of serotonin and dopamine function in obsessive-compulsive disorder. Psychiatry Res 42: 41-51.
42. Marazziti D., Masala I., Rossi A., Hollander E., Presta S., Giannaccini G., (2000) Increased inhibitory activity of protein kinase C on the serotonin transporter in OCD. Neuropsychobiology 41: 171-177. (Pubitemid 30258974)
43. Marazziti D., Mungai F., Vivarelli L., Dellosso B., (2004) Critical issues in the pharmacological treatment of obsessive-compulsive disorder. Clin Neuropsychiatry 1: 59-64.
44. Marazziti D., Presta S., Pfanner C., Gemignani A., Rossi A., Sbrana S., (1999) Immunological alterations in adult obsessive-compulsive disorder. Biol Psychiatry 15: 810-814. (Pubitemid 29460907)
45. Marazziti D., Rossi A., Gemignani A., Giannaccini G., Pfanner C., Milanfranchi A., Presta S., Lucacchini A., Cassano GB., (1996) Decreased platelet 3H-paroxetine binding in obsessive-compulsive patients. Neuropsychobiology 34: 184-187. (Pubitemid 26382047)
46. Martini E., D™Hautcourt JL., Lawry J., O'Connor JE., Sansonetti F., (1990) First European Quality Control of Cellular Phenotyping by Flow Cytometry. Paris: Frison-Roche.
47. Martino D., Church AJ., Defazio G., Dale RC., Quinn NP., Robertson MM., (2005) Soluble adhesion molecules in Gilles de la Tourette™s syndrome. J Neurol Sci 234: 79-85. (Pubitemid 40910347)
48. Montgomery SA., (1994) Pharmacological treatment of obsessive-compulsive disorder. In: E Hollander., J Zohar., D Marazziti., B Olivier., (eds). Current Insights in Obsessive-Compulsive Disorder. Chichester: Wiley and Sons, pp. 123-137.
49. Morer A., Vinas O., Lazaro L., Bosch J., Toro J., Castro J., (2005) D8/17 monoclonal antibody: an unclear neuropsychiatric marker. Behav Neurol 16: 1-8. (Pubitemid 41132447)
50. Morer A., Vinas O., Lazaro L., Calvo R., Andres S., Bosch J., (2006) Subtyping obsessive-compulsive disorder: clinical and immunological findings in child and adult onset. J Psychiatr Res 40: 207-213. (Pubitemid 43214627)
51. Murphy TK., Benson N., Zaytoun A., Yang M., Braylan R., Ayoub E., (2001) Progress toward analysis of D8/17 binding to B cells in children with obsessive compulsive disorder and/or chronic tic disorder. J Neuroimmunol 120: 146-151. (Pubitemid 33016734)
52. Murphy TK., Goodman WK., Fudge MW., Williams RC., Ayoub EM., Dalal M., (1997) B lymphocyte antigen D8/17: a peripheral marker for childhood-onset obsessive-compulsive disorder and Tourette™s syndrome? Am J Psychiatry 154: 402 - 407. (Pubitemid 27098292)
53. Navalta JM., Sedlock DA., Park KS., McFarlin BK., (2007) Neither gender nor menstrual cycle phase influence exercise-induced lymphocyter apoptosis in untrained subjects. Appl Physiol Nutr Metab 32: 481-486.
54. Nie NH., Hull CH., Steinbrenner K., Bent DH., (1998) Statistical Package for the Social Science (SPSS), fourth ed. New York: McGraw-Hill.
55. Pallanti S., Hollander E., Bienstock C., Koran L., Leckman J., Marazziti D., (2002) Treatment non-response in OCD: methological issues and operational definitions. Int J Neuropsychopharmacol 5: 181-191. (Pubitemid 34669829)
56. Pallanti S., Quercioli L., (2006) Treatment-refractory obsessive-compulsive disorder: methodological issues, operational definitions and therapeutic lines. Prog Neuropsychoparmacol Biol Psychiatry 30: 400-412.
57. Perlmutter SJ., Leitman SF., Garvey MA., Hamburger S., Feldman E., Leonard HL., (1999) Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet 354: 1153-1158. (Pubitemid 29460444)
58. Perna FM., Schneiderman N., LaPerriere A., (1997) Psychological stress, exercise and immunity. Int J Sport Med 18: 78 - 83.
59. Piccinelli M., Pini S., Bellantuono C., Wilkinson C., (1995) Efficacy of drug treatment in obsessive-compulsive disorder. Br J Psychiatry 166: 424-443.
60. Rabkin JG., Wagner G., Rabkin R., (1994) Effects of sertraline on mood and immune status in patients with major depression and HIV illness: an open trial. J Clin Psychiatry 55: 433-439.
61. Ravindran AV., Griffiths J., Merali Z., Anisman H., (1995) Lymphocyte subsets associated with major depression and dysthymia: modification by antidepressant treatment. Psychosom Med 57: 555-563.
62. Ravindran AV., Griffiths J., Merali Z., Anisman H., (1998) Circulating lymphocyte subsets in major depression and dysthymia with typical or atypical features. Psychosom Med 60: 283-289. (Pubitemid 28279972)
63. Ravindran AV., Griffiths J., Merali Z., Anisman H., (1999) Circulating lymphocyte subsets in obsessive compulsive disorder, major depression and normal controls. J Affect Disord 52: 1-10. (Pubitemid 29232028)
64. Sallee FR., Richman H., Beach K., Sethuram G., Nesbitt L., (1996) Platelet serotonin transporter in children and adolescents with obsessive-compulsive disorder or Tourette™s syndrome. J Am Acad Child Adolesc Psychiatry 35: 1647-1656. (Pubitemid 26403631)
65. Schleifer SJ., Keller SE., Camarino E., Thornton JC., Stein M., (1983) Suppression of lymphocyte stimulation following bereavement. J Am Med Assoc 250: 374-377.
66. Schlesinger M., Yodfat Y., Rabinowitz R., Bronner S., Kark JD., (1993) Psychosocial stress and NK cells among members of a communal settlement. Adv Exp Med Biol 335: 247-254. (Pubitemid 23294320)
67. Simpson HB., Huppert JD., Petkova E., Foa EB., Liebowitz MR., (2006) Response versus treatment in obsessive-compulsive disorder. J Clin Psychiatry 67: 269-276. (Pubitemid 43357474)
68. Singer HS., Hong JJ., Yoon DY., Williams PN., (2005) Serum autoantibodies do not differentiate PANDAS and Tourette syndrome from controls. Neurology 65: 1701-1707. (Pubitemid 43754397)
69. Sluzewska A., Rybakowski JK., Laciak M., Mackiewicz A., Sobieska M., Wiktorowicz K., (1995) Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Ann N Y Acad Sci 762: 474-476.
70. Smith JM., Shen Z., Wira CR., Fanger MW., Shen L., (2007) Effects of the menstrual cycle status and gender on human neutrophil phenotype. Am J Reprod Immunol 58: 111-119. (Pubitemid 47097377)
71. Swedo SE., (2002) Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS). Mol Psychiatry 7: 24-25.
72. Swedo SE., Leonard HL., Garvey M., Mittleman B., Allen AJ., Perlmutter S., (1998) Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry 155: 264-271. (Pubitemid 28074291)
73. Swedo SE., Leonard HL., Kiessling LS., (1994) Speculations on antineuronal antibody-mediated neuropsychiatric disorders of childhood. Pediatrics 93: 323-326. (Pubitemid 24047173)
74. Swedo SE., Leonard HL., Mittleman BB., Allen AJ., Rapoport JL., Dow SP., (1997) Identification of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a marker associated with rheumatic fever. Am J Psychiatry 154: 110-112. (Pubitemid 27020203)
75. Thomsen PH., (2000) Obsessive-complusive disorder: pharmacological treatment. Eur Child Adolesc Psychiatry 9: 76-84.
76. Thoren P., Asberg M., Cronholm B., (1980) Clomipramine treatment of obsessive-compulsive disorder: a controlled clinical trial. Arch Gen Psychiatry 37: 1281-1289.
77. Tolin DF., Abramowitz JS., Diefenbach GJ., (2005) Defining response in clinical trials for obsessive-compulsive disorder: a signal detection of the Yale-Brown obsessive-compulsive scale. J Clin Psychiatry 66: 1549-1557. (Pubitemid 43068694)
78. Warren RP., Margaretten NC., Pace NC., Foster A., (1986) Immune abnormalities in patients with autism. J Autism Dev Disord 16: 189-197. (Pubitemid 16116775)
79. Weisz JL., McMahon WM., Moore JC., Augustine NH., Bohnsack JF., Bale JF., (2004) D8/17 and CD19 expression on lymphocytes of patients with acute rheumatic fever and Tourette™s disorder. Clin Diagn Lab Immunol 11: 330-336. (Pubitemid 38380814)
80. Weizman R., Carmi M., Hermesh H., Shahar A., Apter A., Tyano S., (1986) High-affinity imipramine binding and serotonin uptake in platelets of eight adolescent and ten adult obsessive-compulsive patients. Am J Psychiatry 143: 335-339. (Pubitemid 16034093)
81. Yovel G., Shakhar K., Ben-Eliyahu S., (2001) The effects of sex, menstrual cycle, and oral contraceptives on the number and activity of natural killer cells. Gynecol Oncol 81: 254-262. (Pubitemid 32424171)
82. Zabriskie JB., (1986) Rheumatic fever: a model for the pathological consequences of microbial-host mimicry. Clin Exp Rheumatol 4: 65-73. (Pubitemid 16166427)
83. Zisook S., Shucter SR., Irwin M., Darko CF., Sledge P., Resovsky K., (1994) Bereavement, depression and immune function. Psychiatr Res 52: 1-10. (Pubitemid 24158098)
84. Zohar J., Chopra M., Sasson Y., Amiaz R., Amital D., (2000) Obsessive compulsive disorder: serotonin and beyond. World J Biol Psychiatry 1: 92-100.
85. Zohar J., Insel TR., (1987) Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment and pathophysiology. Biol Psychiatry 22: 667-687. (Pubitemid 17101476)
86. Zohar J., Mueller EA., Insel TR., Zohar-Kadouch RC., Murphy DL., (1987) Serotonergic responsivity in obsessive-compulsive disorder. Arch Gen Psychiatry 44: 946-951.